NYU LANGONE HEALTH
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1841-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.nyulangone.org
Community-based Approaches to Treating Hypertension and Colon Cancer Prevention
- Conditions
- Interventions
- First Posted Date
- 2010-03-24
- Last Posted Date
- 2015-04-22
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 740
- Registration Number
- NCT01092078
- Locations
- 🇺🇸
NYU School of Medicine, New York, New York, United States
Irinotecan and Bevacizumab for Recurrent Ovarian Cancer
- Conditions
- Interventions
- First Posted Date
- 2010-03-23
- Last Posted Date
- 2015-11-24
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 29
- Registration Number
- NCT01091259
- Locations
- 🇺🇸
Bellevue Hospital Center (NYU Langone Medical Center affiliate), New York, New York, United States
🇺🇸New York University Clinical Cancer Center, New York, New York, United States
Continuous Glucose Monitoring in Type 2 Diabetes Mellitus
- Conditions
- First Posted Date
- 2010-03-09
- Last Posted Date
- 2019-02-06
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 28
- Registration Number
- NCT01083043
- Locations
- 🇺🇸
Winthrop University Hospital, Mineola, New York, United States
Asthma Education Using Child Life Services and an Asthma-based Computer Game
- Conditions
- First Posted Date
- 2010-02-19
- Last Posted Date
- 2020-02-28
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 27
- Registration Number
- NCT01072123
- Locations
- 🇺🇸
Winthrop University Hospital, Mineola, New York, United States
Effectiveness and Duration of Effect of Open Treatment in Attention Deficit Hyperactivity Disorder (ADHD) Patients Treated With Lisdexamfetamine Dimesylate(Vyvanse)
- First Posted Date
- 2010-02-18
- Last Posted Date
- 2018-04-03
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 40
- Registration Number
- NCT01070394
- Locations
- 🇺🇸
NYU School of Medicine, New York, New York, United States
Practice-based Trial of Blood Pressure Control in African Americans
- Conditions
- Interventions
- First Posted Date
- 2010-02-17
- Last Posted Date
- 2013-11-13
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 194
- Registration Number
- NCT01070056
- Locations
- 🇺🇸
Woodhull Medical & Mental Health Center, Brooklyn, New York, United States
🇺🇸Governeur Hospital, New York, New York, United States
🇺🇸Bellevue Hospital Center, New York, New York, United States
Faith-based Approaches in the Treatment of Hypertension (FAITH)
- Conditions
- Interventions
- First Posted Date
- 2010-02-09
- Last Posted Date
- 2016-03-01
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 373
- Registration Number
- NCT01065831
- Locations
- 🇺🇸
NYU School of Medicine, New York, New York, United States
DECIFER: Depression and Citalopram In First Episode Recovery
- First Posted Date
- 2009-12-31
- Last Posted Date
- 2019-12-17
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 95
- Registration Number
- NCT01041274
- Locations
- 🇺🇸
New York University Langone Medical Center/ Bellevue Hospital, New York, New York, United States
Prolonged Emend in a Study (NYU 03-67) of Oxaliplatin and Topotecan in Previously Treated Ovarian Cancer
- First Posted Date
- 2009-11-23
- Last Posted Date
- 2015-03-18
- Lead Sponsor
- NYU Langone Health
- Registration Number
- NCT01017809
- Locations
- 🇺🇸
NYU Clinical Cancer Center, New York, New York, United States
Topotecan With Erlotinib for Topotecan Pretreated Ovarian Cancer
- First Posted Date
- 2009-10-29
- Last Posted Date
- 2016-06-30
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 6
- Registration Number
- NCT01003938
- Locations
- 🇺🇸
Bellevue Hospital Center, New York, New York, United States
🇺🇸NYU Clinical Cancer Center, New York, New York, United States
🇺🇸Tisch Hospital, New York, New York, United States